NL-OMON24514招募中不适用
iposoluble vitamins in patients receiving long-term octreotide treatment.
prof. dr. EGE de VriesUniversitair Medisch Centrum Groningen9700 RB Groningenthe Netherlands0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients are eligible when they have used octreotide for at least 18 months. Patients must be 18 years or older and must be willing to give written informed consent.
排除标准
- •No informed consent, age less then 18 years.
研究者
相似试验
尚未招募
不适用
iposoluble vitamins in patients receiving long-term octreotide treatmentliposoluble vitamin deficiencyshortage of liposoluble vitamins10047635NL-OMON32903niversitair Medisch Centrum Groningen80
已完成
不适用
Vitamine suppletion by morbide obase patientNL-OMON39275Alysis Zorggroep400
已完成
4 期
Vitamin Deficiencies and Supplementation in Morbidly obeseNL-OMON38253Rijnstate Ziekenhuis50
进行中（未招募）
不适用
Vitamin deficiencies and supplement in overweight patientsVitamin B12 deficienciesEUCTR2013-004835-60-NLRijnstate Hospital
已完成
不适用
Vitamin Replacement in AbetalipoproteinemiaAbetalipoproteinemiaNCT00004574National Heart, Lung, and Blood Institute (NHLBI)1